Therma Bright Inc. (TSXV: THRM)

Market Cap	18.07M
Revenue (ttm)	4.47K
Net Income (ttm)	-2.73M
Shares Out	451.63M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,218,826
Average Volume	1,521,375
Open	0.0400
Previous Close	0.0350
Day's Range	0.0350 - 0.0400
52-Week Range	0.0050 - 0.1000
Beta	2.67
RSI	46.20
Earnings Date	Apr 2, 2025

About Therma Bright

Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. The company’s products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; V...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: THRM

Financial Performance

In 2024, Therma Bright's revenue was 6,015, an increase of 192.56% compared to the previous year's 2,056. Losses were -2.45 million, -34.94% less than in 2023.